These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 30244138)
1. Huachansu suppresses TRPV1 up-regulation and spinal astrocyte activation to prevent oxaliplatin-induced peripheral neuropathic pain in rats. Hao Y; Luo X; Ba X; Wang J; Zhou S; Yang S; Fang C; Jiang C; Sun W Gene; 2019 Jan; 680():43-50. PubMed ID: 30244138 [TBL] [Abstract][Full Text] [Related]
2. Cinobufacini protects against paclitaxel-induced peripheral neuropathic pain and suppresses TRPV1 up-regulation and spinal astrocyte activation in rats. Ba X; Wang J; Zhou S; Luo X; Peng Y; Yang S; Hao Y; Jin G Biomed Pharmacother; 2018 Dec; 108():76-84. PubMed ID: 30218861 [TBL] [Abstract][Full Text] [Related]
3. Blocking PAR2 attenuates oxaliplatin-induced neuropathic pain via TRPV1 and releases of substance P and CGRP in superficial dorsal horn of spinal cord. Chen K; Zhang ZF; Liao MF; Yao WL; Wang J; Wang XR J Neurol Sci; 2015 May; 352(1-2):62-7. PubMed ID: 25829079 [TBL] [Abstract][Full Text] [Related]
4. Puerarin suppresses TRPV1, calcitonin gene-related peptide and substance P to prevent paclitaxel-induced peripheral neuropathic pain in rats. Wu Y; Chen J; Wang R Neuroreport; 2019 Mar; 30(4):288-294. PubMed ID: 30676543 [TBL] [Abstract][Full Text] [Related]
5. [Role of Transient Receptor Potential Channels in Paclitaxel- and Oxaliplatin-induced Peripheral Neuropathy]. Taguchi K Yakugaku Zasshi; 2016; 136(2):287-96. PubMed ID: 26831807 [TBL] [Abstract][Full Text] [Related]
6. Anti-allodynic effect of Buja in a rat model of oxaliplatin-induced peripheral neuropathy via spinal astrocytes and pro-inflammatory cytokines suppression. Jung Y; Lee JH; Kim W; Yoon SH; Kim SK BMC Complement Altern Med; 2017 Jan; 17(1):48. PubMed ID: 28088201 [TBL] [Abstract][Full Text] [Related]
7. Oxaliplatin-induced changes in expression of transient receptor potential channels in the dorsal root ganglion as a neuropathic mechanism for cold hypersensitivity. Chukyo A; Chiba T; Kambe T; Yamamoto K; Kawakami K; Taguchi K; Abe K Neuropeptides; 2018 Feb; 67():95-101. PubMed ID: 29274843 [TBL] [Abstract][Full Text] [Related]
8. Glial role in oxaliplatin-induced neuropathic pain. Di Cesare Mannelli L; Pacini A; Micheli L; Tani A; Zanardelli M; Ghelardini C Exp Neurol; 2014 Nov; 261():22-33. PubMed ID: 24967684 [TBL] [Abstract][Full Text] [Related]
10. The α9α10 nicotinic receptor antagonist α-conotoxin RgIA prevents neuropathic pain induced by oxaliplatin treatment. Pacini A; Micheli L; Maresca M; Branca JJ; McIntosh JM; Ghelardini C; Di Cesare Mannelli L Exp Neurol; 2016 Aug; 282():37-48. PubMed ID: 27132993 [TBL] [Abstract][Full Text] [Related]
11. Allopregnanolone prevents and suppresses oxaliplatin-evoked painful neuropathy: multi-parametric assessment and direct evidence. Meyer L; Patte-Mensah C; Taleb O; Mensah-Nyagan AG Pain; 2011 Jan; 152(1):170-181. PubMed ID: 21071147 [TBL] [Abstract][Full Text] [Related]
12. Preventing oxaliplatin-induced neuropathic pain: Using berberine to inhibit the activation of NF-κB and release of pro-inflammatory cytokines in dorsal root ganglions in rats. Ni W; Zheng X; Hu L; Kong C; Xu Q Exp Ther Med; 2021 Feb; 21(2):135. PubMed ID: 33376517 [TBL] [Abstract][Full Text] [Related]
13. [The molecular mechanism of oxaliplatin-induced peripheral neuropathic pain]. Yang SM; Wu SB; Wu JM; Huang JB; Huang MJ; Xiong DL; Hao Y; Sun WP; Xiao LZ Zhonghua Yi Xue Za Zhi; 2021 Nov; 101(43):3581-3587. PubMed ID: 34808752 [No Abstract] [Full Text] [Related]
14. Oxaliplatin neurotoxicity involves peroxisome alterations. PPARγ agonism as preventive pharmacological approach. Zanardelli M; Micheli L; Cinci L; Failli P; Ghelardini C; Di Cesare Mannelli L PLoS One; 2014; 9(7):e102758. PubMed ID: 25036594 [TBL] [Abstract][Full Text] [Related]
15. Blocking of cytokines signalling attenuates evoked and spontaneous neuropathic pain behaviours in the paclitaxel rat model of chemotherapy-induced neuropathy. Al-Mazidi S; Alotaibi M; Nedjadi T; Chaudhary A; Alzoghaibi M; Djouhri L Eur J Pain; 2018 Apr; 22(4):810-821. PubMed ID: 29282807 [TBL] [Abstract][Full Text] [Related]
16. HCN2 contributes to oxaliplatin-induced neuropathic pain through activation of the CaMKII/CREB cascade in spinal neurons. Liu X; Zhang L; Jin L; Tan Y; Li W; Tang J Mol Pain; 2018; 14():1744806918778490. PubMed ID: 29806529 [TBL] [Abstract][Full Text] [Related]
17. Sex-related differences in oxaliplatin-induced changes in the expression of transient receptor potential channels and their contribution to cold hypersensitivity. Miguel CÁ; Noya-Riobó MV; Brumovsky PR; Villar MJ; Coronel MF Neurosci Lett; 2022 Sep; 788():136863. PubMed ID: 36067900 [TBL] [Abstract][Full Text] [Related]
18. Phytochemicals of Cinnamomi Cortex: Cinnamic Acid, but not Cinnamaldehyde, Attenuates Oxaliplatin-Induced Cold and Mechanical Hypersensitivity in Rats. Chae HK; Kim W; Kim SK Nutrients; 2019 Feb; 11(2):. PubMed ID: 30791474 [TBL] [Abstract][Full Text] [Related]
19. Botulinum toxin type A reduces hyperalgesia and TRPV1 expression in rats with neuropathic pain. Xiao L; Cheng J; Zhuang Y; Qu W; Muir J; Liang H; Zhang D Pain Med; 2013 Feb; 14(2):276-86. PubMed ID: 23301515 [TBL] [Abstract][Full Text] [Related]
20. MiR-30b-5p attenuates oxaliplatin-induced peripheral neuropathic pain through the voltage-gated sodium channel Na Li L; Shao J; Wang J; Liu Y; Zhang Y; Zhang M; Zhang J; Ren X; Su S; Li Y; Cao J; Zang W Neuropharmacology; 2019 Jul; 153():111-120. PubMed ID: 31054938 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]